Average Co-Inventor Count = 2.49
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Jenrin Discovery, Inc. (27 from 27 patents)
2. Dupont Pharmaceuticals Company (7 from 106 patents)
3. Dupont Pharmaceuticals, Inc. (4 from 15 patents)
4. Bristol-myers Squibb Pharma Company (3 from 234 patents)
5. Academic Pharmaceuticals, Incorporated (3 from 17 patents)
6. Bristol-myers Squibb Compnay (1 from 3,681 patents)
7. Bristol-myers Squibb Pharma Corporation (1 from 10 patents)
8. Jensen Discovery, Inc. (1 from 1 patent)
9. Jenrm Discovery, Inc. (1 from 1 patent)
10. Searle & Co. (0 patent)
11. Fowler, Kerry W. (0 patent)
12. Chorvat, Robert J. (0 patent)
13. Snyder, James P. (0 patent)
48 patents:
1. 11731938 - Ultra short acting anti-arrhythmic agents
2. 11286235 - Ultra short acting anti-arrhythmic agents
3. 11179370 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
4. 10793519 - Ultra short acting anti-arrhythmic agents
5. 10617673 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
6. 9987253 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
7. 9517228 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
8. 9133127 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
9. 8853252 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10. 8716265 - 4-quinolinemethanols as anti-malarial agents
11. 8680131 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
12. 8648072 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
13. 8580768 - Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
14. 8541475 - MAO-B inhibitors useful for treating obesity
15. 8334282 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes